| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 12/09/2010 | US20100311844 Spontaneously Forming Ellipsoidal Phospholipid Unilamellar Vesicles |
| 12/09/2010 | US20100311812 RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 12/09/2010 | US20100311786 Mono- or bicyclic carboxylic acids as off-note blockers |
| 12/09/2010 | US20100311706 Method of treatment of allergic rhinitis |
| 12/09/2010 | US20100311687 Polysaccharides derivatised with citric acid |
| 12/09/2010 | US20100311670 Conjugates of hydroxyalkyl starch and a protein, prepared by native chemical ligation |
| 12/09/2010 | US20100311654 Modified Polysaccharide-Based Delivery of Nucleic Acids |
| 12/09/2010 | US20100311105 Methods of delivery of exogenous proteins to the cytosol and uses thereof |
| 12/09/2010 | US20100311050 Compositions and methods for the diagnosis and treatment of tumor |
| 12/09/2010 | US20100310658 Electroprocessed Fibrin-Based Matrices and Tissues |
| 12/09/2010 | US20100310613 Drug delivery system |
| 12/09/2010 | US20100310594 Recombinant adenylate cyclase toxin of bordetella induces t cell responses against tumoral antigens |
| 12/09/2010 | US20100310551 Immunogenic, monoclonal antibody |
| 12/09/2010 | US20100310539 Method for manufacturing mesoporous materials, materials so produced and use of mesoporous materials |
| 12/09/2010 | US20100310510 N-terminally chemically modified protein compositions and methods |
| 12/09/2010 | US20100310506 Immunoconjugates for the Treatment of Tumours |
| 12/09/2010 | US20100310468 Recombinant albumins fused with poly-cysteine peptide and the methods for preparing the same |
| 12/09/2010 | DE10200657B4 2:1-Komplex aus β- oder γ-Cyclodextrin und α-Tocopherol 2: 1 complex of β- or γ-cyclodextrin and α-tocopherol |
| 12/09/2010 | CA2841499A1 Compositions and methods for preventing sternal wound infections |
| 12/09/2010 | CA2764482A1 Compositions and methods for delivery of materials |
| 12/09/2010 | CA2764477A1 Ophthalmic formulations, methods of manufacture, and methods of using same |
| 12/09/2010 | CA2764424A1 Vaccine for mycoplasma infection |
| 12/09/2010 | CA2764329A1 Omega-3 oil containing ophthalmic emulsions |
| 12/09/2010 | CA2764326A1 Therapeutic ophthalmic emulsions |
| 12/09/2010 | CA2764230A1 Proteins modified with (amino)-monosaccharide-biotin adduct |
| 12/09/2010 | CA2764197A1 Alginate oligomers for use in overcoming multidrug resistance in bacteria |
| 12/09/2010 | CA2764195A1 Treatment of acinetobacter with alginate oligomers and antibiotics |
| 12/09/2010 | CA2764110A1 Rejuvenating coronary artery by improving blood flow with the help of insertion of nano-balls (encapsulated nanoparticles) containing therapeutic agents by non implantable devicefor tissues and thereby providing in tissue release to address the required cell cycle |
| 12/09/2010 | CA2764051A1 Stabilised composition comprising at least one adrenergic compound |
| 12/09/2010 | CA2764050A1 Stabilised composition comprising at least one adrenergic compound |
| 12/09/2010 | CA2763935A1 Methods for identification of sites for igg conjugation |
| 12/09/2010 | CA2761959A1 Conjugation methods |
| 12/08/2010 | EP2258848A1 Il-17 homologous polypeptide and therapeutic uses thereof |
| 12/08/2010 | EP2258742A1 Polyhydroxyalkanoate compositons having controlled degradation rates |
| 12/08/2010 | EP2258728A1 Phosphorylcholine conjugates for use as vaccine |
| 12/08/2010 | EP2258724A1 Modulating immune responses using multimerized anti-CD83 antibodies |
| 12/08/2010 | EP2258721A1 Polyethylene glycolated lactoferrin complex and method of producing the same |
| 12/08/2010 | EP2258407A2 Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures |
| 12/08/2010 | EP2258402A2 Dried composition |
| 12/08/2010 | EP2258401A2 Folate-receptor targeted imaging agents |
| 12/08/2010 | EP2258400A2 Multivalent VLA-4 antagonists comprising polymer moieties |
| 12/08/2010 | EP2258399A2 Multivalent VLA-4 antagonists comprising polymer moieties |
| 12/08/2010 | EP2258398A1 Albumin-amyloid peptide conjugates and uses thereof |
| 12/08/2010 | EP2258397A1 Polymer conjugate of physiologically active substance |
| 12/08/2010 | EP2258396A1 Transdermally absorbable preparation |
| 12/08/2010 | EP2258395A1 Therapeutic agent for fibroid lung |
| 12/08/2010 | EP2258394A1 Oral dosage form comprising a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient |
| 12/08/2010 | EP2258380A1 Substance and composition both capable of imparting heat resistance |
| 12/08/2010 | EP2258373A1 Composition comprising taurolidine and/or taurultam for the treatment of cancer |
| 12/08/2010 | EP2258368A2 Pharmaceutical compositions for nasal delivery |
| 12/08/2010 | EP2258355A1 Patch |
| 12/08/2010 | EP2258352A2 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| 12/08/2010 | EP2258351A2 Granules containing lansoprazole in large amount |
| 12/08/2010 | EP2258348A2 Method for preparing microparticles having a selected polymer molecular weight |
| 12/08/2010 | EP2257624A2 Methods and compositions |
| 12/08/2010 | EP2257587A1 Polymer derived from linear polyethylenimine for gene transfer |
| 12/08/2010 | EP2257312A2 Nanoparticles for targeted delivery of active agents to the lung |
| 12/08/2010 | EP2257311A1 Conjugated factor viii molecules |
| 12/08/2010 | EP2257304A1 Sustained release poloxamer containing pharmaceutical compositions |
| 12/08/2010 | EP2257291A2 Pyridazine derivatives and their use as therapeutic agents in the treatment of skin disorders |
| 12/08/2010 | EP2257276A2 Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
| 12/08/2010 | EP2257274A2 Treatment of aneurysm with application of connective tissue stabilization agent in combination with a delivery vehicle |
| 12/08/2010 | EP1628685B1 Antiviral phosphonate analogs |
| 12/08/2010 | EP1553924B1 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system |
| 12/08/2010 | EP1427750B1 Modified transferrin fusion proteins |
| 12/08/2010 | EP1322318B1 Use of probiotic lactic acid bacteria for preventing ultraviolet radiation induced inflammatory or allergic reaction or immunosuppression in the skin |
| 12/08/2010 | EP1321144B1 Eye drops |
| 12/08/2010 | EP1116483B1 Oil-in-water emulsion composition |
| 12/08/2010 | EP0772619B2 Immunomodulatory oligonucleotides |
| 12/08/2010 | CN1993113B Particles comprising a core of calcium phosphate nanoparticles, a biomolecule and a bile acid, methods of manufacturing, therapeutic use thereof |
| 12/08/2010 | CN1984644B Stabilised supersaturated solid solutions of steroidal drugs |
| 12/08/2010 | CN1981739B Esmolol preparation |
| 12/08/2010 | CN1969992B Pharmaceutical composition for treating acne and application method thereof |
| 12/08/2010 | CN1968715B Polymeric coupling agents and pharmaceutically-active polymers made therefrom |
| 12/08/2010 | CN1964699B Dry-form composition for oral ingestion and gel-form composition for oral ingestion of type prepared at time of use |
| 12/08/2010 | CN1938034B ED-71 preparation |
| 12/08/2010 | CN1933856B Cream-gel containing ivermectin |
| 12/08/2010 | CN1913923B Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells |
| 12/08/2010 | CN1853644B Treatment and prophylaxis of diseases and infections pigs and poultry |
| 12/08/2010 | CN1823745B Patch |
| 12/08/2010 | CN1774414B New non-ionic surfactants for solubilizing poorly soluble molecules |
| 12/08/2010 | CN1646174B Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier |
| 12/08/2010 | CN1537526B Method for delievering materials into skin and compositions used therein |
| 12/08/2010 | CN1430513B Topical formulations for the transdermal delivery of niacin and method of treating hyperlipidemia |
| 12/08/2010 | CN101910202A Biocompatible three dimensional matrix for the immobilization of biological substances |
| 12/08/2010 | CN101910198A Antibodies which bind selectively to hair of animals and an antibody based drug delivery system for animals |
| 12/08/2010 | CN101910116A Method for production of (2E,6Z,8E)-N-isobutyl-2,6,8-decatrienamide (spilanthol), and foods, beverages, cosmetics and pharmaceutical preparations each comprising the compound |
| 12/08/2010 | CN101909655A Method of delivering an anti-cancer agent to a cell |
| 12/08/2010 | CN101909654A Nanoemulsions |
| 12/08/2010 | CN101909653A Composition exhibiting high osmotic antimicrobial, anti-inflammatory and regeneration activity |
| 12/08/2010 | CN101909652A Dry powder formulations comprising ascorbic acid derivates |
| 12/08/2010 | CN101909651A External preparation composition comprising fatty acid-based ionic liquid as active ingredient |
| 12/08/2010 | CN101909640A Composition for improving nutritional status, reducing frequency of fever and/or increasing immunocompetence of elderly |
| 12/08/2010 | CN101909619A Composition comprising sesamin component and quercetin glycoside |
| 12/08/2010 | CN101909607A Transdermal therapeutic system having urea components |
| 12/08/2010 | CN101909606A Antipruritic sheet |
| 12/08/2010 | CN101909602A Oral powder and granular antitumor agent |
| 12/08/2010 | CN101909601A Method to enhance aqueous solubility of poorly soluble actives using methoxypolyethylene glycol |
| 12/08/2010 | CN101909599A Counter-pressure filtration of proteins |
| 12/08/2010 | CN101909592A External preparation for skin |